NASDAQ:ATXI
Avenue Therapeutics, Inc. Stock News
$4.40
+0.200 (+4.76%)
At Close: May 08, 2024
Avenue Therapeutics Reports Second Quarter 2020 Financial Results and Recent Corporate Highlights
11:30am, Friday, 14'th Aug 2020
NEW YORK, Aug. 14, 2020 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today
What's in Store for Avenue Therapeutics (ATXI) in Q2 Earnings?
04:53pm, Tuesday, 04'th Aug 2020
Avenue Therapeutics' (ATXI) sole pipeline candidate, tramadol, is under review. With lower clinical activities, operating expenses are likely to have declined during the second quarter.
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know
09:50pm, Tuesday, 28'th Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $10.30, moving -1.9% from the previous trading session.
Avenue Therapeutics, Inc. (ATXI) Stock Sinks As Market Gains: What You Should Know
09:50pm, Wednesday, 22'nd Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $10.40, moving -1.61% from the previous trading session.
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
12:30pm, Tuesday, 21'st Jul 2020
NEW YORK, July 21, 2020 -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a company focused on the development of intravenous (“IV”) tramadol for the U.S. market, today.
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know
09:50pm, Thursday, 16'th Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $9.83, moving -0.91% from the previous trading session.
Avenue Therapeutics, Inc. (ATXI) Dips More Than Broader Markets: What You Should Know
09:50pm, Thursday, 09'th Jul 2020
Avenue Therapeutics, Inc. (ATXI) closed the most recent trading day at $9.75, moving -1.52% from the previous trading session.
Is Avenue Therapeutics (ATXI) Stock Outpacing Its Medical Peers This Year?
03:30pm, Thursday, 09'th Jul 2020
Is (ATXI) Outperforming Other Medical Stocks This Year?
Pacira (PCRX) Provides Preliminary Results for Second Quarter
03:50pm, Tuesday, 07'th Jul 2020
Pacira (PCRX) reports preliminary results for the second quarter of 2020. The company's product sales are hurt by the COVID-19 pandemic. The stock fell in pre-market trading.
Fortress Biotech Added to Russell 3000® Index
12:30pm, Monday, 29'th Jun 2020
Annual Russell indexes’ reconstitution captures the 4,000 largest U.S. stocks as of May 8, ranking them by total market capitalization. Membership in the U.S. all-cap Russell 3000® Index, which re
Veru (VERU) Soars: Stock Adds 6.9% in Session
12:44pm, Thursday, 25'th Jun 2020
Veru (VERU) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Avenue Therapeutics, Inc. (ATXI) Upgraded to Strong Buy: Here's What You Should Know
04:00pm, Wednesday, 24'th Jun 2020
Avenue Therapeutics, Inc. (ATXI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 1 (Strong Buy).
New Strong Buy Stocks for June 24th
03:18pm, Wednesday, 24'th Jun 2020
New Strong Buy Stocks for June 24th
Avenue Therapeutics' Shares March Higher, Can It Continue?
02:38pm, Tuesday, 23'rd Jun 2020
As of late, it has definitely been a great time to be an investor in Avenue Therapeutics
Aclaris Gets FDA Nod to Start Investigator-led Coronavirus Study
02:12pm, Thursday, 18'th Jun 2020
Aclaris (ACRS) announces that it supports an IND application to evaluate its oral investigational MK2 inhibitor compound, ATI-450, in hospitalized patients with COVID-19.
